STOCKSCOPE

Woodside Energy (ASX: WDS): Why We're Watching This LNG Giant After a 41% Rally

Mark Elzayed

Mark Elzayed

CIO at Vestra Capital

Published:15 Oct 2026
Woodside Energy (ASX: WDS): Why We're Watching This LNG Giant After a 41% Rally

Woodside Energy (ASX: WDS) has caught our attention after its shares surged 41% year to date. We like the combination of a major LNG expansion, improving cash flow and a potentially significant production milestone approaching. But after such a strong rally, the key question is whether its next phase of growth can deliver the earnings and cash generation needed to justify investor optimism.

The numbers tell an interesting story

Woodside's first-half results showed improving financial performance, although substantial project investment remains a key consideration.

  • Revenue: US$7.45 billion, up 13% year on year.
  • Underlying net profit: US$1.33 billion, up 7%.
  • Operating cash flow: US$3.01 billion.
  • Free cash flow: US$352 million, compared with US$136 million a year earlier.
  • Gearing: 20.6%, slightly above management's 10% to 20% target range.

Scarborough could be the next catalyst

The Scarborough Energy Project was 98% complete in Woodside's August half-year results, with first LNG cargo targeted for the fourth quarter of 2026.

We see this as an important milestone. Bringing Scarborough online could increase production capacity and strengthen future revenue, although the benefits will depend on commissioning, operating costs, LNG prices and the pace of the production ramp-up.

Woodside is also investing in other major developments, including Trion in Mexico and Louisiana LNG in the US. These projects offer longer-term growth opportunities, but they also demand substantial capital.

Can growth translate into stronger returns?

Woodside's 2026 production guidance stands at 174 million to 185 million barrels of oil equivalent. However, higher production alone will not guarantee better shareholder returns.

The key question is whether additional output can generate enough cash to fund investment, maintain dividends and protect the balance sheet.

Investor Insight: Follow the cash

We think free cash flow is the metric investors should watch most closely. If Scarborough begins delivering additional production while capital expenditure moderates, Woodside could have greater financial flexibility. If spending remains elevated or commissioning is delayed, the benefits to shareholders could take longer to emerge.

The next milestone matters

Woodside's upcoming quarterly update should help investors assess operational progress and spending. We will be looking for evidence that its growth ambitions are translating into tangible financial returns.

For us, the attraction is the combination of an established LNG business and new production potential. After a 41% year-to-date rally, can Woodside's next phase of growth deliver enough cash flow to keep the momentum going?

Mark Elzayed

Mark Elzayed

(CIO at Vestra Capital)

Mark Elzayed is a prominent Australian financial executive and portfolio strategist with over a decade of hands-on capital markets experience. Having successfully managed over $100M+ in FUM across volatile economic cycles, Mark founded Vestra Capital to democratize institutional-grade quantitative strategies and privileged ASX deal flow for Australian investors.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore
Market Briefings
Market Briefings

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore

Australian equities: what moved the ASX 200? Australian shares finished lower on Friday, 6 November, as the technology-led sell-off on Wall Street spread across global markets. The ASX 200...

Mark ElzayedMark Elzayed•
Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test
Biotech & Health
Biotech & Health

Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test

Epiminder Limited ASX: EPI has expanded the US market for its epilepsy monitoring technology following a significant regulatory clearance, strengthening its commercial prospects ahead of a p...

Danny AadDanny Aad•
Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?
Mining
Mining

Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?

A 38-metre gold intersection grading 2.1 grams per tonne has given Asara Resources Limited ASX: AS1 an encouraging exploration result beyond its established Massan deposit in Guinea. The dis...

Alison ElzayedAlison Elzayed•
Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?
Mining
Mining

Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?

Alvo Minerals Limited ASX: ALV has extended rare earth mineralisation approximately 2 kilometres beyond previously tested areas at its Boa Vista prospect in Brazil, strengthening the explora...

Alison ElzayedAlison Elzayed•
Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet
Mining
Mining

Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet

Avenira Limited ASX: AEV has reached a significant financing milestone, with its $48.9 million rights issue providing fresh capital to advance the Wonarah Phosphate Project in the Northern T...

Alison ElzayedAlison Elzayed•
Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?
Biotech & Health
Biotech & Health

Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?

Mayne Pharma Group Limited ASX: MYX is taking a decisive step towards becoming a US-focused pharmaceutical company, agreeing to sell its international operations for $55.5 million. The tran...

Danny AadDanny Aad•
Loading more stories...